cellulitis – Faulty Drugs

Monday, November 25, 2024

Latest:

Pfizer withdraws all lots of OXBRYTA (voxelotor)
Wegovy lawsuit
Tepezza Lawsuit
The key factors that could contribute to the emergence of a new pandemic virus
FDA recalls Quinapril linked to Cancer

Faulty Drugs

Faulty Pharmaceutical Drugs Resources

August 12, 2008

Vivitrol and risk of adverse injection site reactions

FDA is notifying healthcare professionals of the risk of adverse injection site reactions in patients receiving naltrexone (Vivitrol). Physicians should